Summary of Changes
- RSI version 3.0. This has been updated to reflect the significant updates to the toxicities in the latest versions of the Summary of Product Characteristics (SPC)s from the manufacturers for Vincristine and Zoledronic acid.
MHRA approval [.pdf]
MHRA cover letter [.pdf]
Notification of a substantial amendment [.pdf]
EE2012 RSI-v3.0 [.pdf]